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A chemical modification approach was used in this study to identify the active site serine residue of human pancreatic lipase. Purified human 
pancreatic lipase was covalently modified by incubation with [‘HI, [“Cjtetrahydrolipstatin (THL). a potent inhibitor of pancreatic lipase. The 
radiolabeled lipase was digested with thermolysin, and the peptides were separated by HPLC. A single THL-peptidc-adduct was obtained which 
was identical to that obtained earlier from porcine pancreatic lipase. This pentapeptide with the sequence VIGHS is covalently bound to a THL 
molecule via the side chain hydroxyl group of the serine unit corresponding toSer-152 of the lipase. The selective cleavage of the THL-serine bond 
by mild acid treatment resulted in the formation of the B-lactone Ro 404441 in high yield snd clearly proves that THL is attached via an ester 
bond and with retention of stereochemistry at all chiral centers to the side chain hydroxyl group of Ser-152 of the lipase. The results obtained for 
human pancreatic lipase corroborate the inhibition mechanism of THL found on the porcine enzyme, and are in full agreement with the 
identification of the Ser-lS2...His-263...Asp-176 catalytic triad in the X-ray structure of human pancreatic lipase. 
Human pancreatic lipase active-site serine; Tetrahydrolipstatin (THL); Structure of lipase-THL adduct 
1. INTRODUCTION 
Pancreatic lipase (triacylglycerol acyl-hydrolase, EC 
3.1 .1.3) is one of the two predominant lipolytic enzymes 
secreted by the pancreas. The preferred substrates for 
pancreatic lipase are emulsified triglycerides. The high 
activity of pancreatic lipase at an oil-water interface 
requires several properties that are not found in en- 
zymes acting on soluble substrates [l]. Numerous stud- 
ies have identified amino acids or regions of the protein 
that may be important for the interfacial activation or 
the catalytic activity of lipase. Most studies have used 
chemical modification experiments or spectral methods 
[2-S]. However, the reliability of both approaches is 
unknown. Although several groups have demonstrated 
that porcine pancreatic lipase (pPL) is a serine-type s- 
terase with Ser-152 as the active-site serine [S-9], the 
lipolytic mechanism of human pancreatic lipase (hPL) 
is still only based on the functional and structural simi- 
larities, as well as on the high degree of sequence homol- 
ogy, to the porcine enzyme. In addition, it was postu- 
Abbreviations: CZE, capillary zone clectrophoresis; FABMS, fast 
atom bombardment mass pectrometry; FHHA, S-formylleucyloxy-2- 
hcxyl-Zhexadecenoic a id; hPL, human pancreatic lipase; pPL, 
porcine pancreatic lipase; TFA, trifluoroacetic a id: THL, tetrahydro- 
lipstatin. The residues of human pancreatic lipase are numbered ac- 
cording to the sequence of porcine pancreatic lipasc [10,17j. 
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iated from the lipase crystal structure determination 
that Ser-152’ would be the acylable serine in the enzyme 
and participate in the catalytic activity of hPL [IO]. 
Tetrahydrolipstatin (THLz), a potent inhibitor of 
pancreatic lipase [ll-141, blocks fat absorption selec- 
tively, and has been shown in several animal models to 
have a&obesity and anti-hypercholesterolemlc activ- 
ity [6]. THL was used to identify the active-site serine 
in pPL [6]. Since THL inhibits hPL with similar char- 
teristics as the pPL, we have used this inhibitor to exper- 
imentally verify the postulated role of Ser.152 in hPL. 
The mechanism of inhibition of hPL by THL is of spe- 
cial interest, since its understanding is a prerequisite for 
the design of structurally new lipase inhibitors as poten- 
tial anti-obesity drugs. 
Our results clearly identify the THL binding site on 
hPL and precisely define the binding mode of the inhib- 
itor to the side chain hydroxyl group of Ser-152. The 
data presented are in full agreement with the identiflca- 
tion of the Ser-152, His-263, Asp-176 trypsin-like cata- 
lytic triad in the X-ray structure of hPL. 
2. EXPERIMENTAL 
Tetmhydrolipstadn (THL, IW* 495.75, Scheme I), [‘I-B and 
[“q,THL ([‘I-II at C(3’), C(4’), CW), C(7’); [“Cl: C(1)) as well as the 
pemapeptide VIGHS were obtained as described in [6]. hPL was 
obtained from Prof. B. Eorgstrbm, Lund [IS]. The model compounds 
Ro 40-4441 and Ro 43.3042 wen: synthesized according to 1161. Ro 
42-7476 (II-IL-butanol ester adduct) was prepared from TI-IL and 
lithiumbutanolate. Thermolysin was a product of Set% All other 
reagents were of the highest grade obtained from Merck, Fluka and 
Sigma. 
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Scheme 1. Schematic representation f the formation of an ester bond between the side chain hydroxyl group of Ser- 152 of human pancreatic lipase 
(pathway i, nuclcophilic attack of type ~) and the excluded alternative formation of an ether bond (pathway ii, nucleophilic attack of type fl). 
Chemical degradation ofVIOHS(THL). The identification ofthe reaction products Re 40-4441 (t.l.c., 91 .S% conversion) and VIGHS (CZE) proves 
the ester structure of VIGHS(THL). a) 1% p.toluene-suJfoni¢ acid monohydrate inacetonitrile, 24 h, room temperature. 
2.1. Isolation and characterization of [JH]. [UCJTHL modred pep. 
tides 
The purified hPL was modified by [~H], [t4C]THL similarly as de- 
scribed for pPL [6]. The lipaso activity was assessed using triolein as 
substrate [14]. The radioactively abeled THL-lipas, was extracted 
with chloroform:methanol (1:2.5) to remove unreacted THL and then 
digested using thermolysin 5 M urea at 47°C for 26 h. The thermo- 
lysin-di~ested peptides were chromatographed on HPLC (Vydac C4 
x 0.46 cm, 5 ~), Two solvents were used. A: 0,1% TFA in H:O; B: 0.1% 
TFA in 70% acetonitrile in H=O. The pooled radiolaheled fractions 
wore farther purified on a RP C8 column 02 x 0.4 cm, 5/z, Merck) 
using a gradient of 20 mM sodium phosphate inH~O, pH 7.0, and 20 
mM sodium phosphate, pH 7.0, in 60% acetonitrile. The radiolabeled 
fractions were finally desalted on a Vydac C4 column, 
The amino acid analysis and FABM$ characterization f the iso- 
lated THL-boand peptides, as well as the derivatization fthe peptide 
adduce B, were carried out similarly as described in [6], N-Terminal 
sequencing was carried out on an Applied Biosystems 475A Protein 
Sequencer. Due to the long alkyi chains pre~nt in THL, a covalent 
sequencing protocol was derived, employing immobilization of the 
sample via an acrylamine linker to a Sequelon-AA (Millipore, 
Bedford, USA), polyvinylidentrifluoride (PVDF) membrane. 
2.2. Acid hydrolysis of the THL-peptlde adduce A
20/~1 of 1% toluene-sulfonio acid in acetonitrile was added to 6/zg 
of the isolated THL-peptid¢ A, and the mixture was incubated for 24 
h at room temperature. 20/zl of triethyim'nine was then added, and the 
mixture wan evaporated. 1 nmol of the product was dissolved in 10/zl 
of water (0.05 metal) for CZE. The rest of the contents was then 
developed on silica gel t,l.¢, in CH2CI=:(CH3CH:)20 (9:1). 
2.3. Capillary zone lectrophoresis ( CZE) 
The experiments were carried out on an apparatus Model 270A, 
Applied Biosystcms, Samples were loaded hydrodynamically by 
applying vacuum into a fused-silica capillary column. Each load was 
carried out for 1 s. The capillary column (50/~m ×72 cm) was primed 
with 200 mM sodium phosphate, pH 2.5, and the ~amplcs were sop. 
arated at 25 kV with a current of 100/~A for 25 rain, maintaining the 
capillary column at 30"C. Separated components were monitored at 
200 nm. 
3. RESULTS AND DISCUSSION 
3.1. Isolation and characterization of  [~H], [t*C]THL- 
modified peptides 
In the currem study, the incubation o fhPL  with THL  
resulted in incorporation of 0.89 mol o f  THL  per mol 
of  the lipase (M~ 52,000). This almost 1:1 stoichiometry 
of  the interaction with hPL was in good agreement with 
the results reported for pPL and the lipases from other 
species [11,14]. The [3I-I], [~4C]THL-labeled protein was 
then subjected to thgrmolysin cleavage. After purifica- 
tion on HPLC,  two [3H], [t4C]THL-peptides, A and B, 
were obtained. The results of amino acid analysis and 
N-terminal s~uenc ing  of  the THL-pept id¢ A, com- 
bined with the finding that a molecular ion doublet at 
1,007.6/1,009.6 Da for pcptide A and at 1,050.4/1,052.4 
Da for pcpt id,  B is foarM in the FABM$ (data not 
shown), irMicat¢ clearly that a H-Val- I le-Gly-His-Ser- 
OH l~ntapeptide is covalently bound to THL  in both 
the isolated fractions, A and B, the only difference being 
112 
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Scheme 2. Mass spectrometric fragmentation scheme of peptide B derivatized with a tcrt.-butyloxycarboayl group at the imidazole of His. 
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Fig. I. Up~r  mass range of the FAB mass spectrum of the isolated 
pcptid¢ B derivatized with a tert.-butyloxycarbonyl group. 
an extra carbamoyl group at the N-terminal valine of 
peptide B (Scheme 2). Such a derivative could easily 
have been generated as an artifact during the thermo- 
lysin digestion in the presence of urea. All these data 
indicate that the two THL-peptides isolated are identi- 
cal to those obtained with pPL [6]. Sequence alignment 
based on the primary structure of the lipase reported by 
Winkler ¢t al. [10] shows that the pentapeptide can only 
correspond to VaI-148-SCr-152 of hPL, as this is the 
only sequence in the lipase which contains these five 
amino acids. 
3.2. Determination of THL binding site and binding 
mode 
Theoretically, the pentapeptido, VIGHS, contains 
tWO residues which can covalently react with the ~- 
lactone moiety of THL, namely the imidazole of 
histidine and the hydroxyl of serin¢. With the synthetic 
pentapeptide VIGHS, two tert.-butyloxylcarbonyl 
groups can be introduced, one at the N-terminal and 
one at the imidazol¢ of histidine. Using the same reac- 
tion conditions, one tert.-butyloxylearbonyl group has 
been introduced into the THL-pentapeptide B whose 
N-terminal is blocked by a earbamoyl group as shown 
by FABMS, which yielded a (M+Na)"-molecular ion 
doublet at 1,172.7/1,174.8 Da, and (M+2Na)'-molecu- 
lar ion doublet at 1,194.7/1,196.6 (Fig. 1 and Scheme 2). 
This experiment clearly demonstrates the presence of a 
free imidazole unit in histidine and therefore confirms 
that THL is bound to SCr-152 of the lipas¢. 
A covalent attachment ofa THL molecule to $¢r-152 
of hPL is possible ither via an ester bond as already 
postulated in the ease of pPL [6], or via an ether link 
(Schemes 1and 4). The THL-butanol addact, Re 42- 
7476, has been synthesized as a model compound with 
an ester bond between a THL unit and an alcohol 
moiety. Under mild acidic conditions, butanol is lib- 
erated and the THL rearranges cleanly and in high yield 
(78% isolated) to the dklactone Re 40.4441 with S- 
stereochemistry at all 4 chiral centers (Scheme 3). The 
treatment of the THL-pentapeptide adduct A under 
identical conditions (Schemes 1 and 4) leads to the 
cleavage of the THL-pentapeptide bond and to the 
almost exclusive formation of Re 40.4441.91.5% of the 
 :,Co"O H 0 
Us) t ' 
""'~-C6Ht3 
THL.batanol este~ a¢lduct Ro 42,7476 
. )  (s) I , , . . .~)  + ,.tanol 
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Scheme 3, Rearrangement of th¢ THL-butanol ester adduet, Ro 42.7:,76, to the $-laetono Re 40-4441 and butanol; model reaction for the 
VIGHS(THL) ester adduct cleavage, a) 1% p-toluene-sulfonic acid monohydrate in aeetonitrile, 6 h, room temperature, 78% isolated yield. 
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Scheme 4. Postulated egradation of a hypothetical VIGHS(THL) ether adduct. This pathway can be excluded, since no Ro 43-2042 and at most 
8.S% (t.1.c.) of FHHA was observed under degradation conditions a), a) 1% ptoluene-sulfonic acid monohydrate in acetonitrile, 24 h, room 
temperature. Pathway i) represents he possible reaction products induced by elimination of type bl; pathway ii) represents the possible reaction 
products induced by elimination of type j?. 
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Fig. 2, Comparison of CZE electropherograms of untreated THL- 
peplide A (El), acid hydrolysis products of THL-peptidc A (E2), 
synlhetic VIGHS pntapeptide reference (E3) and the mixtum of both 
acid hydrolysis products of THLspeptide A and the VIGHS reference 
(64). The experimental conditions are described in section 2, 
radioactivity in the degradation mixture co-migrated 
with a synthetic reference of &lactone Ro 40-4441 on 
t.1.c (Ar O&31), whereas 8.5% of the radioactivity was 
observed in the Rr region 0.00-0.05. The material re- 
covered from the t.l.c.-spot with a Rr 0.31 showed a 
3H-to-14C ratio similar to that of the originally used 
THL, which is in full agreement with the structure of Ro 
40-4441. The formation of the isomeric &lactone Ro 
43-2042 (Rr 0.25) can be excluded. 
A THL-pentapeptide with an ether link must have an 
inverted stereochemical center at position 3. Such a 
compound is expected to be stable under the mild acidic 
conditions used (Scheme 4). Forced degradation under 
acidic conditions could only lead to elimination pro- 
cesses producing either Ro 43-2042 and VIGH- 
dehydro-A (type a) or giving the unsaturated acid 
FHHA together with VIGHS (type /J). The formation 
of Ro 43-2042 and of substantial amounts of FHHA 
have been excluded, thus confirming that the THL mol- 
ecule is attached to Ser-152 via an ester link and with 
retained S-stereochemistry at all 4 chiral centers with a 
structure as drawn for the VIGHS(THL) ester adduct 
in Scheme 1. 
The peptide products of the acid hydrolysis of the 
THL-peptide A were identified by CZE. Fig. 2 shows 
four electropherograms (El-E4). Electropherogram El
(of untreated THL-peptide A) is only poorly resolved, 
probably due to the hydrophobicity of the THL-adduct 
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and its poor solubility in the electrophoretic buffer sys- 
tem, E2, however, produced after acid hydrolysis of 
THL-peptide A, is well resolved and shows one major 
peak. Electropherogram E3 shows the migration pat- 
tern of the synthetic reference VIGHS pentapeptide. In 
E4 the acid hydrolysis product of THL-peptide A and 
the reference VIGHS pentapeptide were co-injected in 
a molar ratio of 1:2. Based on migration-time com. 
parison, the major peak at ca. 10.6 min in E2 could 
clearly be identified as newly formed VIGHS penta- 
peptide as a result of the acid hydrolysis. The second 
compound formed (Scheme 1), the THL-degradation 
product, Re 40-4441, cannot be seen by this technique, 
but has separately been identified by silica gel t.l.c, as 
shown above. 
This study clearly demonstrates that covalent 
modification of lipase by THL followed by thermolysin 
digestion leads to the formation of the same peptide- 
THL adduct in the case of hPL as described earlier for 
pPL [6]. The present work provides in addition further 
evidence that THL is bound to the side chain hydroxyl 
group of Set-152 via an ester bond to the carbonyl 
function of the fl-lactone moiety (Scheme 1) and with 
retention of stereochemistry at all 4 chiral centers. 
Taken together, this study fully confirms the hypothesis 
that hPL follows a serine hydrolase mechanism with 
Ser-152 as the active site serine. 
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